Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.47ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.47NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.41 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.41 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.41 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.41 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.71ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.71ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.71NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AS.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AS.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AS.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.142ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.142ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.142ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.142NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.166ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.166ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.166ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.166NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.4.11 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.4.11 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.11 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.11 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.34.2 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.34.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.34.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.34.2 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.50ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.50NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.60ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.60ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.60NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.52ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.52ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used